OLIG2 and MGMT are well-expressed in glioblastoma patients. To confirm the expression of key diagnostic markers in glioblastoma (GBM), we performed immunohistochemical staining on GBM tissue samples obtained from diagnostic cases in our department. This evidence concerns the gene OLIG2 and glioblastoma.